Seroconversions After Withdrawal From Mycophenolate Mofetil in Solid Organ Transplant Recipients Without a Third Dose of BNT162b2 mRNA Coronavirus Disease 2019 Vaccine: A Case Series.

Morishita, Tetsuji; Sakai, Akiyoshi; Matsunami, Hidetoshi

Morishita, Tetsuji; Sakai, Akiyoshi; Matsunami, Hidetoshi.

Morishita T; Department of Internal Medicine, Matsunami General Hospital, Gifu, Japan.
Sakai A; Matsunami Research Park, Gifu, Japan.
Matsunami H; Department of Clinical Laboratory, Matsunami General Hospital, Gifu, Japan.

Transplantation ; 106(4): e238-e239, 2022 04 01.

Article in English | MEDLINE | ID: covidwho-1625540

Subject(s)

COVID-19; Organ Transplantation; BNT162 Vaccine; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Humans; Immunosuppressive Agents/adverse effects; Mycophenolic Acid/adverse effects; Organ Transplantation/adverse effects; RNA, Messenger; Seroconversion; Transplant Recipients

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Organ Transplantation / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Language: English Journal: Transplantation Year: 2022 Document Type: Article Affiliation country: Tp.0000000000004043

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google